Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Charging infrastructure remains one of the biggest hurdles for widespread EV adoption.
The e-commerce and media titan is in talks with veteran TV news anchor Brian Williams to host an election night special, Variety reported.
Dallas-based Steward Health Care is may just well be the poster child for private equity investment in healthcare gone wrong.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
TikTok is calling it quits on a music streaming business that barely made it out the door, and only launched trials last year.
The Biden administration is introducing a ban on both hardware and software for “connected vehicles” from China and, incidentally, Russia.
A group of 14 large banks and other financial institutions announced that they’re going to up their support for the nuclear power industry.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The insurance industry needs to be careful when using AI, or else AI black boxes could render consumers uninsurable without any explanation.
Walmart will soon roll out an option that would allow consumers to pay for online orders directly via instant bank account transfers.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.